April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
A Mouse Model of Limbal Stem Cell Deficiency Induced by Topical Medication of Benzalkonium Chloride
Author Affiliations & Notes
  • Zhirong Lin
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Tong Zhou
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Huan He
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Xiaochen Liu
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Hui He
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Zuguo Liu
    Ophthalmology, Eye Institute of Xiamen University, Xiamen City, Fujian Province, China
  • Footnotes
    Commercial Relationships  Zhirong Lin, None; Tong Zhou, None; Huan He, None; Xiaochen Liu, None; Hui He, None; Zuguo Liu, None
  • Footnotes
    Support  the National Natural Science Foundation of China (NSFC, No. 30872810, 30910270), the Ministry of Science and Technology of China (863 Program, No. 2006AA02A131)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2018. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zhirong Lin, Tong Zhou, Huan He, Xiaochen Liu, Hui He, Zuguo Liu; A Mouse Model of Limbal Stem Cell Deficiency Induced by Topical Medication of Benzalkonium Chloride. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2018.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To develop a mouse model of limbal stem cell deficieny induced by topical administration of benzalkonium chloride and investigate the possible mechanisms.

Methods: : Benzalkonium Chloride (BAC) at concentrations ranging from 0% to 0.5% was applied to the mouse ocular surface for 28 days. Scoring of length of new vessels (NV), corneal inflammatory index and fluorescent staining test were performed to evaluate the toxic effects of BAC on the ocular surface. Global specimens were collected on day (D) 28 and labeled with a series of antibodies including cytokeratin 12 (K12), cytokeratin 19 (K19), connexin 43 (Cx43), P63, ABCG2, EGF-receptor, β-catenin, CD4, cytokeratin 10 (K10), Ki67. In situ TUNEL assay and transmission electron microscopy (TEM) were also applied. TKE2 cells was cultured for MTT assay.

Results: : BAC at concentration of 0.5% four times per day successfully induced typical manifestations of limbal stem cell deficiency, including corneal neovascularization, severe stromal inflammation, and diffuse epithelial staining. Conjunctiva-specdific K19 and Cx43 was positive in the corneal surface after BAC treatment. The stem cell associated markers, P63, ABCG2, EGF-receptor, and β-catenin were absent in the limbal basal epithelium. CD4 was present in the corneal stroma. K10 emerged in the corneal and conjunctival surface. TUNEL assay revealed extensive apoptosis in the entire cornea and limbal zone. TEM showed the irregular basement membrane and the loss of stem cell-specific ultrastructure at the limbus. MTT revealed the apparent decrease of proliferative capacity in TKE2 cells after BAC treatment.

Conclusions: : Topical administration of 0.5% BAC at high frequency in mouse induces changes resembling that of limbal stem cell deficiency in humans, and thus, represents a novel model of limbal stem cell deficiency.

Keywords: cornea: epithelium • pathology: experimental • ocular irritancy/toxicity testing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×